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Abstract
Introduction:  Polyglandular  syndrome  is  characterized  by  the  association  of  autoimmune,
organ-speciﬁc,  endocrine  and  non-endocrine  diseases.
Objective:  To  present  a  case  of  polyglandular  syndrome  type  III  (b)  accompanied  by  pernicious
anemia and  autoimmune  thyroiditis.
Method:  Report  the  clinical  case  of  a  young  patient  that  developed  progressive  and  disabling
peripheral  neuropathy  framework,  triggered  by  vitamin  B12  deﬁciency.
Discussion:  It  was  proven  that  atrophic  gastritis  with  positive  intrinsic  anti-factor  was  respon-
sible for  the  framework  of  pernicious  anemia,  which  in  turn  dangerously  reduced  the  serum
levels of  vitamin  B12,  leading  to  myelopathy.  There  was  a  progressive  neurological  improve-
ment after  parenteral  cyanocobalamin  replacement,  keeping  the  patient  at  ambulatory,  under
maintenance  therapy.
Conclusion:  The  importance  of  suspecting  on  polyglandular  syndrome  in  the  presence  of
autoimmune  frameworks  is  important,  especially  those  involving  diabetes,  thyroiditis,  atrophic
gastritis,  pernicious  anemia,  vitiligo,  among  others.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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Síndrome  Poliglandular  Tipo  III  e  Neuropatia  Periférica  Grave:  Uma  Associac¸ão
Incomum
Resumo
Introduc¸ão:  A  Síndrome  Poliglandular  é  caracterizada  pela  associac¸ão  de  doenc¸as  autoimune
órgão-especíﬁcas,  endócrinas  e  não  endócrinas.
Objetivo:  Apresentar  um  caso  de  Síndrome  Poliglandular  do  tipo  III  (b)  acompanhada  de  anemia
perniciosa e  tireoidite  auto-imune.
Método:  Relata-se  o  caso  clínico  de  uma  paciente  jovem  que  desenvolveu  quadro  de  neuropatia
periférica  progressiva  e  incapacitante,  desencadeada  pela  deﬁciência  de  vitamina  B12.
Discussão: Ficou  comprovado  que  a  gastrite  atróﬁca  com  anticorpo  anti-fator  intrínseco  positivo
foi responsável  pelo  quadro  de  anemia  perniciosa,  que  por  sua  vez  reduziu  perigosamente  os
níveis séricos  da  vitamina  B12.  Houve  melhora  progressiva  do  quadro  neurológico  após  reposic¸ão
parenteral  da  cianocobalamina,  mantendo-se  a  paciente,  em  seguimento  ambulatorial,  sob
terapia de  manutenc¸ão.
Conclusão:  Ressalta-se  a  importância  de  se  suspeitar  da  síndrome  poliglandular  na  vigência  de
quadros auto-imunes,  especialmente  aqueles  envolvendo  diabetes,  tireoidites,  gastrite  atró-
ﬁca, anemia  perniciosa,  vitiligo,  entre  outros.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos
os direitos  reservados.
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E. Introduction
utoimmune  polyglandular  syndrome  (APS)  was  ﬁrst
escribed  in  1926  by  Schmidt,  through  necropsies  on
atients  with  adrenal  insufﬁciency,  in  which  destructive  and
on-speciﬁc  lymphocyte  inﬁltration  was  found  both  in  the
hyroid  gland  as  in  the  cortex  of  adrenal  glands.1
The  APS  is  characterized  by  the  association  of
rgan-speciﬁc  autoimmune  diseases,  endocrine  and  non-
ndocrine.2 It  is  divided  into  four  types:  (a)  APS  I,  charac-
erized  by  the  presence  of  at  least  two  of  the  following
ituations,  Addison’s  disease,  chronic  hypoparathyroidism
nd  chronic  candidiasis;  (b)  APS  II,  characterized  by  the
resence  of  Addison’s  disease  associated  with  autoimmune
hyroiditis  disease  and/or  diabetes  mellitus  1;  (c)  APS  III,
haracterized  by  the  presence  of  autoimmune  thyroid  dis-
ase  with  other  autoimmune  disease  (such  as  diabetes
ellitus  1,  atrophic  gastritis  and  pernicious  anemia,  vitiligo,
lopecia  and  myasthenia  gravis),  except  for  Addison’s  dis-
ase  and/or  hypoparathyroidism;  (d)  APS  IV,  characterized
y  the  combination  of  autoimmune  diseases  that  do  not  fall
nto  the  categories  already  mentioned.3
The  APS  I  and  II  are  rare,  with  a  prevalence  of
:9.000--1:200,000  inhabitants  and  1.4--4.5  cases  per
00,000  inhabitants,  respectively.  However,  the  epidemio-
ogical  aspects  of  the  SPA  III  and  IV  are  not  fully  known.4
The  polyglandular  syndrome  type  III,  in  turn,  can  be  sub-
ivided  according  to  the  autoimmune  disease  associated:
PA  III  (a),  when  the  patient  has  diabetes  mellitus  1;  SPA  III
b),  characterized  by  the  presence  of  atrophic  gastritis  and
ernicious  anemia;  SPA  III  (c)  when  there  is  vitiligo,  severe
lopecia  or  myasthenia.1
This  article  reports  a  case  of  a  young  woman  with
olyglandular  syndrome  type  III  (b),  which  developed
 progressive  and  disabling  peripheral  neuropathy  with
a
b
(yelopathy,  triggered  by  vitamin  B12  deﬁciency.  It  was
roven  that  atrophic  gastritis  with  positive  intrinsic  anti  fac-
or  antibody  lead  to  pernicious  anemia  that  regressed  after
yanocobalamin  administration.
. Clinical case
emale  patient  34  years  old,  was  referred  from  neurologist
o  gastroenterologist  after  six  months  of  symptoms.  She  had
nitiated  the  neurological  symptoms  with  paresthesia  in  the
ower  limbs,  ascending  and  progressive,  in  the  hallux  region
hich  advanced  gradually  to  the  thoracic  region.  After  4
onths  when  she  could  no  longer  walk,  having  dizziness,
oss  of  proprioceptive  sensitivity  and  ataxia.  There  was  no
istory  of  alcoholism,  hypertension,  diabetes  mellitus,  hep-
titis,  use  of  illicit  drugs  and  tattoos.  There  is  reference  to  a
lood  transfusion  3  years  ago  due  to  a  miscarriage.  Reported
wimming  in  the  river  in  childhood.  At  clinical  examination,
ith  regular  condition,  conscious,  color,  eutrophic,  with
araesthesia  and  motor  deﬁcit  in  the  lower  limbs,  impaired
ait,  using  wheelchair  for  mobility.  The  research  conducted
y  the  neurologist  had  already  discarded  the  hypothesis  of
uillain--Barré  syndrome  and  multiple  sclerosis.
The  cerebrospinal  ﬂuid  examination  revealed  no  alter-
tions.  The  MRI  of  the  spine  in  its  thoracic  and  lumbar
egions  showed  multiple  cold  areas  and  modiﬁcation  of
ignal  involving  the  cord  at  various  levels,  showing  hyper-
ntense  signal  on  T2  at  its  periphery.  This  ﬁnding  is  more
ronounced  near  the  tenth  thoracic  vertebra  region,  pre-
ominantly  in  the  anterior-medial  region  of  the  medulla.
lectromyography  showed  polyneuropathy  with  pattern  of
xonal  impairment  in  the  lower  limbs.
The  patient  had  no  gastrointestinal  symptoms,  but  as  the
lood  count  showed  anemia  with  hemoglobin  of  11.2  g/dL
12--15  d/dL),  hematocrit  of  32.9%  (36--48%)  and  high  VGM
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128  3 (81--101  3),  the  upper  digestive  endoscopy  was  indi-
cated,  which  identiﬁed  an  appearance  suggestive  of  body
atrophic  gastritis,  enanthematous/mild  erosive  of  antrum
gastritis,  with  a  negative  urease  test.  Pathologic  result  of
antral  biopsy  revealed  it  to  be  a  mild  chronic  atrophic
gastritis  in  antrum  with  incomplete  interstitial  metapla-
sia.  The  intrinsic  anti-factor  antibody  was  positive  and  the
anti-parietal  cell  antibody  negative;  the  total  abdominal
ultrasonography  revealed  no  alterations.
Serology  for  HIV,  HTLV  1,  VDRL,  hepatitis  B  and  hepatitis
C  virus,  cytomegalovirus,  toxoplasmosis  and  schistosomiasis
were  negative.  Anti-core  factor,  anti-Sm  antibody,  anti-DNA,
anti-cardiolipin,  anti-Ro  were  also  non-reactive.  Amino-
transferases,  PCR  and  ESR  were  within  normal  limits,
but  serum  TSH  was  at  8:34  mIU/mL  (0.35--5.5  mil/mL).
The  rheumatoid  factor  was  negative  and  anti-thyroglobulin
(anti-TG),  anti-tpo  antibodies  were  positive.  The  dosage
of  vitamin  B6  was  6.5  pg/mL  (5.0--30.0  g/L)  and  vitamin
B12  <  50  pg/mL  (210--980  pg/mL)  showing  that  this  is  a  seri-
ous  deﬁciency.
The  serum  vitamin  B12  levels  normalized  after  par-
enteral  administration,  with  progressive  neurological
improvement.
3. Discussion
This  article  reports  the  case  of  a  previously  healthy  young
patient,  who  starts  with  neurological  manifestations,  evolv-
ing  progressively  to  neuropathy  with  myelopathy.  Following,
it  was  detected  the  presence  of  autoimmune  diseases  such
as  pernicious  anemia  with  vitamin  B12  deﬁciency  (pos-
itive  intrinsic  anti-factor  antibody)  and  thyroiditis  (with
anti-thyroglobulin  antibody),  which  led  to  the  diagnosis  of
autoimmune  polyglandular  syndrome  type  III  (b).
A  deﬁciency  of  vitamin  B12  can  lead  to  hematological
changes,  neurological,  psychiatric  and/or  gastrointestinal
impairment.5 The  most  frequent  cause  of  this  deﬁciency
is  pernicious  anemia,  which  is  the  lack  of  intrinsic  fac-
tor  (a  protein  secreted  by  the  parietal  cells  necessary
for  the  absorption  of  vitamin  B12),  consequent  to  autoim-
mune  gastritis.17 The  autoimmune  atrophic  gastritis  is
characterized  by  atrophy  of  the  gastric  body  and  and/or
by  the  presence  of  circulating  autoantibodies  against
parietal  cells  and  their  secretory  products,  as  intrinsic
factor.6
Chronic  autoimmune  destruction  of  proton  pump  H+/k+
ATPase  results  in  decreased  gastric  acid  secretion,  hyper-
gastrinemia  and  iron  deﬁciency.  In  a  more  advanced  stage
of  the  disease,  pernicious  anemia  may  occur  as  a  result
of  vitamin  B12  deﬁciency.6 Deﬁciency  of  this  vitamin  can
cause  demyelination  of  peripheral  nerves  and  the  cen-
tral  nervous  system,  being  associated  with  peripheral
neuropathy.7
Myelopathy  due  to  vitamin  B12  deﬁciency  is  manifested
initially  by  paresthesia  and  weakness,  affecting  all  four
limbs  in  a  symmetrical  pattern.  In  advanced  stages,  there
are  paraplegia  and  varying  degrees  of  spasticity,  associated
with  hyper-  or  hyporeﬂexia,  ataxia,  paresthesia,  alter-
ations  of  deep  sensitivity,  cognitive  dysfunction,  pelvic  ﬂoor
disorders,  decreased  visual  acuity.  The  occurrence  of  sen-
sory  level  is  rarely  observed.9 Initial  laboratory  diagnosis
n
e
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s  based  on  the  serum  vitamin  B12,  which  is  reduced  in
ost  cases.10 Treatment  consists  of  parenteral  replace-
ent  of  vitamin  B12.  Response  to  treatment  is  related
o  the  severity  and  time  between  onset  of  symptoms  and
reatment.9
In  this  case  the  neurological  manifestations  presented
ere  consequence  of  pernicious  anemia  based  on  the  good
esponse  to  cyanocobalamin  and  the  histological  demonstra-
ion  of  atrophic  gastritis  and  the  presence  of  the  intrinsic
nti-factor  antibody.11
Few  reports  in  the  literature  have  described  the
ransverse  myelitis  by  cyanocobalamin  deﬁciency,  with  well-
eﬁned  sensory  level,  as  in  our  case.  Kosik  et  al.12 reported
he  framework  of  a  young  patient  with  a  diagnosis  of  perni-
ious  anemia  with  acute  transverse  myelitis  and  level  at  T10
ue  to  vitamin  B12  deﬁciency.  Vasconcellos  et  al.13 in  turn,
escribed  a  severe  and  fatal  reports  of  transverse  myelitis
ith  sensory  level,  which  did  not  respond  to  replacement
herapy.  According  to  Vasconcellos,  the  presence  of  sen-
ory  level  denotes  severe  case  of  vitamin  B12  deﬁciency  and
ay  be  considered  a  ﬁnding  associated  with  a bad  progno-
is.  In  the  case  presented  here,  the  patient  had  ﬂaccid  and
rreﬂex  paraplegia  with  sensory  level  at  T10;  however,  con-
rary  evidence,  it  evolved  with  a  favorable  prognosis  after
eplacement  of  cyanocobalamin.
The  electroneuromyography  in  cases  of  polyneuropathy
eveals,  in  general,  decreased  or  absent  sensory  nerve
ction  potentials  and  normal  conduction  velocity.16 Nuclear
agnetic  resonance  in  turn  may  show  areas  of  demyelina-
ion  in  the  brain  or  spinal  cord  corresponding  to  areas  of
yperintensity  in  the  sequence  weighted  in  T2.  This  ﬁnding
s  most  commonly  found  in  the  posterior  cord  of  the  mar-
ow.  The  radiological  changes  may  take  up  to  12  months  to
isappear.5,13
In  the  blood  count  is  observed  anemia  and  less  commonly
eukopenia,  besides  thrombocytopenia.  Megaloblastic  ane-
ia  is  present  in  most  cases  and  in  1/3  of  the  cases  may  be
bsent.13 Healton  et  al.10 in  a  study  on  143  patients,  who
ad  a  vitamin  B12  deﬁciency,  observed  that  27.4%  had  nor-
al  hematocrit  and  23%  had  a  normal  MCV.  A  bone  marrow
iopsy  is  usually  hyperplastic,  with  a  predominance  of  red
ell  precursors.16 The  patient  in  this  case  had  anemia  with
igh  MCV,  which  is  the  most  frequent  ﬁnding  according  to
he  literature.  In  the  present  case  there  was  normalization
f  the  MCV  with  treatment.  The  dosage  of  the  intrin-
ic  anti-factor  antibody  is  positive  in  cases  of  pernicious
nemia.
Stabler  et  al.17 have  shown  that  vitamin  B12  deﬁciency
auses  reversible  megaloblastic  anemia,  demyelinating  dis-
ase,  or  both,  and  that  parenteral  replacement  or  high  dose
f  vitamin  B12  orally  is  an  effective  therapy.
Laboratory  diagnosis  of  vitamin  B12  deﬁciency  can  be
ccomplished  through  the  dosage  of  cyanocobalamin  or
omocysteine  and  methylmalonic  acid  in  the  urine.13 How-
ver,  the  dosage  of  homocysteine  and  methylmalonic  acid
ave  better  sensitivity  and  speciﬁcity  than  cyanocobal-
min,  which  has  limited  sensitivity  and  speciﬁcity.14 Though
nfrequent,  deﬁciency  of  vitamin  B12  may  present  with
ormal  or  even  increased  serum  level.15 Liver  disease,  for
xample,  can  increase  the  levels  of  the  transport  proteins
transcobalamins  I  and  III)  with  a  consequent  increase  in
erum  cyanocobalamin.16
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The  detection  of  antibodies  is  sufﬁcient  for  the  diag-
osis  of  autoimmune  disease  of  the  thyroid.  Positive
nti-peroxidase  antibodies  (anti-TPO)  are  strongly  indicative
arkers  of  autoimmune  thyroiditis  and  are  present  in  90%  of
isease  cases  and  currently  used  to  deﬁne  the  existence  of
n  autoimmune  thyroiditis.  Anti-Tg  antibodies  are  present  in
0--50%  of  patients.8 The  presence  of  positive  anti-tpo  and
nti-tg,  associated  with  high  levels  of  TSH  were  enough  for
iagnosis  of  autoimmune  thyroiditis  in  the  case  presented.
The  treatment  is  based  on  the  parenteral  replacement  of
yanocobalamin.16 Some  schemes  are  proposed,  for  exam-
le  1000  mg  IM  twice  a  week  for  two  weeks,  followed  by  a
eekly  dose  for  3  months  and  a  monthly  dose  thereafter.
he  recovery  becomes  evident  after  3--6  months  of  treat-
ent;  after  this  period  the  recovery  is  slow  and  can  last  up
o  years.9
In  conclusion,  spinal  presentation  of  vitamin  B12  deﬁ-
iency  in  the  form  of  transverse  myelitis,  as  synchronous
anifestation  of  polyglandular  syndrome  type  III  (b)  is  a
are  condition,  one  should  suspect  the  vit  B12  deﬁciency
hen  certain  neurological  changes  are  evident.  The  pres-
nce  of  sensory  level  is  explained  by  the  spinothalamic
ract  impairment  as  observed  in  the  present  case  reported.
he  most  commonly  cause  implicated  in  this  deﬁciency,
ccording  to  the  literature,  is  pernicious  anemia.  It  is  a
reatable  disease,  if  diagnosed  early,  have  a  good  prognosis.
ur  patient  showed  with  severe  disabilities  and  neurological
ymptoms  for  6  months  which  could  explain  the  reversal  of
he  neurological  status.  Still,  the  patient  had  sensory  level,
onsidered  a  poor  prognostic  factor  in  cases  of  myelopathy
ue  to  vitamin  B12  deﬁciency,  but  that  progressed  well  after
eplacement  therapy.
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